A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,970,804 shares of EW stock, worth $274 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
2,970,804
Previous 19,200 15372.94%
Holding current value
$274 Million
Previous $1.46 Million 19291.39%
% of portfolio
0.72%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $216 Million - $284 Million
2,970,804 New
2,970,804 $284 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $1.54 Million - $2.07 Million
22,199 New
22,199 $1.54 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $28,590 - $32,536
385 New
385 $31,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $48.6 Million - $60.7 Million
-579,142 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $45.6 Million - $52.5 Million
579,142 New
579,142 $48.4 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $8.56 Million - $10.9 Million
-119,415 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $24.7 Million - $32.1 Million
-367,269 Reduced 75.46%
119,415 $9.53 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $23.4 Million - $31.2 Million
405,835 Added 501.97%
486,684 $33.6 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $2.87 Million - $4.43 Million
54,704 Added 209.23%
80,849 $15.3 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $1.81 Million - $2.08 Million
-25,296 Reduced 49.17%
26,145 $6.1 Million
Q3 2019

Nov 15, 2019

BUY
$61.55 - $75.43 $2.46 Million - $3.02 Million
40,040 Added 351.2%
51,441 $11.3 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $2.43 Million - $2.81 Million
-43,619 Reduced 79.28%
11,401 $2.11 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $535,410 - $716,079
-11,180 Reduced 16.89%
55,020 $10.5 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $2.86 Million - $3.51 Million
61,600 Added 1339.13%
66,200 $10.1 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $210,220 - $266,938
4,600 New
4,600 $801,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $8.49 Million - $10.3 Million
-200,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $2.6 Million - $3.32 Million
70,000 Added 53.85%
200,000 $27.9 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $11.6 Million - $13.6 Million
-344,495 Reduced 72.6%
130,000 $14.7 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $17.2 Million - $18.4 Million
474,495
474,495 $51.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.